Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $70.2B | +$347M | 130 | 1.26% | Increased |
|
| 2 |
BlackRock
New York
| $62.8B | -$42M | 138 | 1.32% | Reduced |
|
| 3 |
Fidelity Investments
Boston,
Massachusetts
| $32.9B | +$2.18B | 117 | 2% | Increased |
|
| 4 |
State Street
Boston,
Massachusetts
| $31.9B | +$319M | 123 | 1.3% | Increased |
|
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
| $17.7B | +$911M | 86 | 2.04% | Increased |
|
| 6 |
Capital World Investors
Los Angeles,
California
| $17.6B | +$291M | 13 | 2.72% | Increased |
|
| 7 |
JP Morgan Chase
New York
| $15.9B | -$1.15B | 133 | 1.21% | Reduced |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $15.8B | -$271M | 56 | 2.77% | Reduced |
|
| 9 |
Geode Capital Management
Boston,
Massachusetts
| $15.6B | -$10.1M | 145 | 1.26% | Reduced |
|
| 10 |
Morgan Stanley
New York
| $15.4B | -$1.41B | 149 | 1.12% | Reduced |
|
| 11 |
Capital International Investors
Los Angeles,
California
| $11.1B | +$388M | 11 | 2.12% | Increased |
|
| 12 |
Norges Bank
Oslo,
Norway
| $9.79B | +$41.7M | 37 | 1.37% | Increased |
|
| 13 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $9.72B | -$32.4M | 18 | 5.86% | Reduced |
|
| 14 |
Capital Research Global Investors
Los Angeles,
California
| $9.26B | +$615M | 7 | 1.93% | Increased |
|
| 15 |
Bank of America
Charlotte,
North Carolina
| $9.18B | +$249M | 147 | 0.74% | Increased |
|
| 16 |
Franklin Resources
San Mateo,
California
| $8.29B | -$57.2M | 58 | 2.33% | Reduced |
|
| 17 |
Massachusetts Financial Services
Boston,
Massachusetts
| $7.85B | -$42M | 23 | 2.34% | Reduced |
|
| 18 |
Northern Trust
Chicago,
Illinois
| $7.26B | -$303M | 123 | 1.19% | Reduced |
|
| 19 |
Bank of New York Mellon
New York
| $6.66B | -$593M | 97 | 1.24% | Reduced |
|
| 20 |
Goldman Sachs
New York
| $5.75B | -$346M | 108 | 0.93% | Reduced |
|
| 21 |
Invesco
Atlanta,
Georgia
| $5.55B | +$549M | 81 | 1.07% | Increased |
|
| 22 |
UBS AM
Chicago,
Illinois
| $5.04B | -$90.7M | 59 | 1.3% | Reduced |
|
| 23 |
Dimensional Fund Advisors
Austin,
Texas
| $5.01B | -$24.5M | 73 | 1.22% | Reduced |
|
| 24 |
Charles Schwab
San Francisco,
California
| $4.86B | +$97.3M | 99 | 0.93% | Increased |
|
| 25 |
Dodge & Cox
San Francisco,
California
| $4.85B | -$46.9M | 5 | 2.74% | Reduced |
|